Last reviewed · How we verify
Henagliflozein and Metformin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Henagliflozein and Metformin (Henagliflozein and Metformin) — Zhujiang Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Henagliflozein and Metformin TARGET | Henagliflozein and Metformin | Zhujiang Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Henagliflozein and Metformin CI watch — RSS
- Henagliflozein and Metformin CI watch — Atom
- Henagliflozein and Metformin CI watch — JSON
- Henagliflozein and Metformin alone — RSS
Cite this brief
Drug Landscape (2026). Henagliflozein and Metformin — Competitive Intelligence Brief. https://druglandscape.com/ci/henagliflozein-and-metformin. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab